Hypoxia within subcutaneously implanted macroencapsulation devices limits the viability and functionality of densely

Samuel A Einstein1,2, Leah V Steyn3, Bradley P Weegman1,4

  • 1Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, United States.

PubMed
Summary

Subcutaneous islet macroencapsulation shows low oxygen levels (PO2) within devices, impacting islet viability. Higher islet density leads to lower viability, suggesting apoptosis is a key factor in cell loss.